Jump to content
Success Stories | Genedata Selector

Your Trusted Partner for NGS-Based Workflows

Our Customers

Discover how Genedata Selector® integrates and analyses NGS data enabling scientists to collaborate, access, and efficiently share results with full transparency and traceability.

Octapharma Increases Scientific Insights with Genedata Selector

Octapharma relies on the in-depth characterization of their engineered production cell lines. NGS is a crucial technology for such complex projects providing versatile applications and high-quality results. Octapharma required an in-house solution to optimize the handling and analysis of NGS data. Genedata Selector supports Octapharma by providing analytical tools that address the needs of users of all levels. The ready-to-use Playbooks, intuitive genome viewer, and tailored workflows empower Octapharma to improve the efficiency of data-related processes and collaboration throughout the organization.

Our Partners' Success Stories

Cell Line Characterization 2.0: Implementation of Sequence Variant Analysis via RNA-seq and Future Perspectives

Benjamin Lindner
Senior Data Scientist, Boehringer Ingelheim


In this webinar, we show RNA-seq as an alternative to Sanger sequencing to confirm the transgene’s transcript sequence. It provides superior sensitivity for mutation detection as well as high specificity, repeatability and robustness. Further, it is scalable up to 96 samples per batch and offers the possibility of automatic bioinformatic analysis.

Request Webinar
A Newly Identified Small RNA Regulates NGNA Sialylation in CHO Cells

Simon Fischer
Senior Principal Scientist & Head of Cell Biology - Cell Line Development, Boehringer Ingelheim

Discover how Boehringer Ingelheim delved deep using NGS to identify the root cause of an unusual recombinant protein product characteristic. Learn how the team of scientists interrogated the differences of cell line phenotypes by exploring changes in the genomic and transcriptomic levels using various sequencing methods.

Request Webinar
Localization and Structural Characterization of Random Transgene Integration of CHO Manufacturing Clones Using Next-Generation Sequencing

Benjamin Lindner
Senior Data Scientist, Boehringer Ingelheim


In this webinar, we present in-depth analysis of the top 3 production clones at Boehringer Ingelheim using TLA technology.  This allowed scientists to better understand the effects of random transgene integration in CHO cells, assess performance characteristics by measuring viability and antibody titers, and perform in-depth genetic characterization critical to assessing cell stability.

Request Webinar
From Transfection to FIH in 6 Months: How Advances in Cell Line Development Enabled Manufacturing of Monoclonal Antibodies at An Unprecedented Pace

Simon Fischer
Senior Principal Scientist & Head of Cell Biology - Cell Line Development, Boehringer Ingelheim


Here we present a case study that resulted in the successful accelerated development of GMP-grade antibody-based therapeutics for early clinical studies at a commercial scale of 2,000 L. Applying innovative cell line generation approaches together with digital technology, resulted in the production of high-quality drug substance in less than 3 months.

Request Webinar

Accelerate Your NGS-Based Workflows

Request a Demo